AKAP8 promotes ovarian cancer progression and antagonizes PARP inhibitor sensitivity through regulating hnRNPUL1 transcription-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

AKAP8 promotes ovarian cancer progression and antagonizes PARP inhibitor sensitivity through regulating hnRNPUL1 transcription

Published:2024-05 Issue:5 Volume:27 Page:109744
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Mobet Youchaou,Wang Haocheng,Wei Qinglv,Liu Xiaoyi,Yang Dan,Zhao Hongyan,Yang Yu,Ngono Ngane Rosalie Anne,Souopgui Jacob,Xu Jing,Liu Tao,Yi Ping

Funder

Natural Science Foundation of Chongqing Municipality

Natural Science Foundation Project of Chongqing

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference30 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA A Cancer J. Clin.,2018

2. Global cancer in women: cancer control priorities;Islami;Cancer Epidemiol. Biomarkers Prev.,2017

3. The current treatment of recurrent ovarian cancer;Herzog;Curr. Oncol. Rep.,2006

4. Preserving replication fork integrity and competence via the homologous recombination pathway;Ait Saada;DNA Repair,2018

5. Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer;González-Martín;N. Engl. J. Med.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP